Arch Therapeutics Appoints Experienced Directors and Executive Leadership

Life science company Arch Therapeutics has appointed Dr. Avtar Dhillon as board chair and Dr. Arthur Rosenthal as director. The company has also appointed Dr. Terrence W. Norchi as president & CEO.

ByAngela Sormani

3 July 2013•5 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

People North America US Briefs

Arch Therapeutics Appoints Experienced Directors and Executive Leadership

Merck

Putnam Investments

Related articles